The disintegration of the merger between Emageon and Health Systems Solutions (HSS) last week could be tied to investment fraud charges brought against a Texas-based international financing company that was expected to back HHS in the deal.

During an internal inspection, the Department of Veterans Affairs (VA) discovered that a contractor providing medical transcription services was not following its medical information privacy rules.

Corepoint Health is the new brand name for NeoTool, under which the company said it will accelerate the expansion of its product and service offerings.

Digisonics reported that it has secured new contracts with hospitals in Massachusetts and Texas.

Healthcare IT developer Emageon has terminated its amended merger agreement with the New York City-based Health Systems Solutions (HSS), due to the latter's failure to receive all necessary financing on or before a designated closing date of Feb. 11.

The death rate associated with PCI in heart attack patients at Massachusetts General Hospital (MGH) in Boston was more than twice the state average, according to an analysis released by the Harvard Medical School Department of Health Care Policy. However, the hospital fared much better in its CABG rates, according to a separate analysis by same organization

BOSTON–Changes in gene expression during chemoradiation can predict thelikelihood of response to therapy for women with locally advancedcervical cancer, according to research presented this week at the 50thannual meeting of the American Society for Therapeutic Radiology andOncology (ASTRO).

BOSTON– Patients receiving proton therapy are at a decreased risk of developing a secondary cancer by two-fold, compared to being treated with standard photon radiation treatment, according to a first-of-its-kind study presented today at the American Society for Therapeutic Radiology and Oncology's (ASTRO) 50th annual meeting.